Overview

Cell Expansion Market Introduction:

Cell Expansion Market is predicted to value over USD 32.18 billion by 2027 end and record a CAGR of over 14.8% during the forecast period 2020 to 2027. 

The consumables segment is leading the market. The prominent factor that has resulted into this escalating global cell expansion market growth is its substantial rise in the number of screenings offering a high throughput, which in turn, increases the usage of consumables throughout the new drug discovery stage. The disposables are predicted to record a faster growth rate over the forecast period owing to the negligible risk related to the cross-contamination of the equipment used in the laboratory and thriving pharmaceutical and biotechnology industry.

Regenerative medicine segment is predicted to dominate the market during the forecast period. There have been advancements in technology in the translational research over the last two decades that are related to tissue engineering and molecular biology that is used in regenerative medicine. It makes sure that the normal cellular activities of internal organs of the human body are properly restored. The clinical diagnostics are garnering the attention of researchers across the world due to advancements made into the companion diagnostic kit technology and rising awareness regarding public health thus resulting in early chronic ailment screenings.

The North America region, with a market share of over 30%, is subjugating the cell expansion market. The prominent factors contributing to the augmentation of the market in the region are increasing incidences of persistent diseases and rising demand for regenerative medicines. According to the research cited by the National Health Council of CDC, over 130 million American citizens are diagnosed with adverse ailments. The European region holds over 25% market share mainly owing to the prevalence of key players such as GE Healthcare, Becton Dickinson & Company Merck Millipore, etc. The Asia Pacific region currently holds over 15% market share owing to a constantly developing infrastructure for healthcare and regulatory environment that is in favour of the local healthcare agencies in the region.

Key market players are:

Thermo Fisher Scientific Inc., Terumo BCT, Merck KGaA, Beckman Coulter Inc., Miltenyi Biotec, Lonza Group Ltd., Stemcell Technologies Inc., GE Healthcare, Corning Inc., Sartorius Stedim Biotech.

Cell Expansion Market Segmentation:

By Product 

• Consumables
• Media
• Reagents
• Sera
• Disposables
• Tissue Culture Flasks
• Bioreactor Accessories
• Other Disposables
• Instruments
• Cell Expansion Supporting Equipment 
• Flow Cytometers
• Centrifuges
• Cell Counters & Haemocytometers
• Other Supporting Equipment 
• Bioreactors
• Microcarrier Bioreactor
• Microcarrier-Based Anchorage-Dependent Bioreactors
• Suspension-Based Anchorage-Independent Bioreactors
• Perfusion/Hollow Fiber Bioreactors
• Automated Cell Expansion Systems

By Cell Type

• Human Cells
• Stem Cells
• Adult Stem Cells
• Induced Pluripotent Stem Cells (IPSCs)
• Embryonic Stem Cells (ESCs)
• Differentiated Cells
• Animal Cells

By Application

• Regenerative Medicine and Stem Cell Research
• Cancer and Cell-Based Research
• Other Applications

By End User

• Biotechnology & Biopharmaceutical Companies
• Research Institutes
• Cell Banks
• Other End Users

By Region

• North America
• Europe
• Asia Pacific
• Rest of the World

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis 
• Key trends 
• Key data-points affecting market growth 

Objectives of the Study:

• To provide with an exhaustive analysis on the global cell expansion market by product, by cell type, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market 
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
        1.1. Objectives of the Study 
        1.2. Market Definition 
        1.3. Market Scope 
               1.3.1. Years Considered for the Study
               1.3.2. Market Covered
        1.4. Currency 
        1.5. Limitations 
        1.6. Stakeholders 
 2.  Research Methodology 
        2.1. Research Data 
               2.1.1. Secondary Data
                          2.1.1.1. Key Data from Secondary Sources
               2.1.2. Primary Data
         2.1.2.1. Key Data from Primary Sources
        2.2. Market Size Estimation 
        2.3. Market Breakdown and Data Triangulation 
        2.4. Assumptions for the Study  
3. Executive Summary
        3.1. Market Outlook
        3.2. Segment Outlook
        3.3. Competitive Insights
4. Global Cell Expansion Market Variables, Trends & Scope
        4.1. Market Lineage Outlook
        4.2. Penetration and Growth Prospect Mapping
        4.3. Industry Value Chain Analysis
        4.4. Cost Analysis Breakdown
        4.5. Technology Overview
        4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Global Cell Expansion Market Overview
        5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Cell Expansion Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Cell Expansion Market Analysis Tools
        6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
        6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
        6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
        6.4. Market Entry Strategies
        6.5. Case Studies
7. Global Cell Expansion Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
        7.1 Consumables 
               7.1.1 Media
               7.1.2 Reagents
               7.1.3 Sera
               7.1.4 Disposables
                          7.1.4.1 Tissue Culture Flasks
                          7.1.4.2 Bioreactor Accessories
                          7.1.4.3 Other Disposables
        7.2 Instruments 
                 7.2.1 Cell Expansion Supporting Equipment
                            7.2.1.1 Flow Cytometers
                            7.2.1.2 Centrifuges
                            7.2.1.3 Cell Counters & Hemocytometers
                            7.2.1.4 Other Supporting Equipment
                7.2.2 Bioreactors
                             7.2.2.1 Microcarrier Bioreactors
                                          7.2.2.1.1 Microcarrier-Based Anchorage-Dependent Bioreactors
                                          7.2.2.1.2 Suspension-Based Anchorage-Independent Bioreactors
                              7.2.2.2 Perfusion/Hollow Fiber Bioreactors
                7.2.3 Automated Cell Expansion Systems
8. Global Cell Expansion Market, By Cell Type Historical Analysis and Forecast 2020-2027 (USD Million)
         8.1 Human Cells 
                8.1.1 Stem Cells
                           8.1.1.1 Adult Stem Cells
                           8.1.1.2 Induced Pluripotent Stem Cells (IPSCS)
                           8.1.1.3 Embryonic Stem Cells (ESCS)
                8.1.2 Differentiated Cells
        8.2 Animal Cells 
9. Global Cell Expansion Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
        9.1 Regenerative Medicine and Stem Cell Research
        9.2 Cancer and Cell-Based Research
        9.3 Other Applications
10. Global Cell Expansion Market, By End-User Historical Analysis and Forecast 2020-2027 (USD Million)
        10.1. Biotechnology & Biopharmaceutical Companies
        10.2. Research Institutes
        10.3. Cell Banks
        10.4. Other End Users
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        11.1. Introduction
        11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  11.2.1. U.S.A
                  11.2.2. Canada
                  11.2.3. Mexico
        11.3. Market Size (USD Million) Forecast for North America 2020-2027 
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        12.1. Introduction
        12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                 12.2.1. Brazil
                 12.2.2. Venezuela
                 12.2.3. Argentina
                 12.2.4. Rest of Latin America
        12.3. Market Size (USD Million) Forecast for Latin America 2020-2027  
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        13.1. Introduction
        13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  13.2.1. Germany
                  13.2.2. U.K
                  13.2.3. France
                  13.2.4. Italy
                  13.2.5. Spain
                  13.2.6. Russia
                  13.2.7. Poland
                  13.2.8. Rest of Europe
        13.3. Market Size (USD Million) Forecast for Europe 2020-2027
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        14.1. Introduction
        14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  14.2.1. Japan
                  14.2.2. China
                  14.2.3. India
                  14.2.4. Australia and New Zealand
                  14.2.5. ASEAN
                  14.2.6. Rest of Asia Pacific
        14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        15.1. Introduction
        15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  15.2.1. Saudi Arabia
                  15.2.2. UAE
                  15.2.3. South Africa
                  15.2.4. Egypt
        15.3. Market Size (USD Million) Forecast for MEA 2020-2027           
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    16.1 Thermo Fisher Scientific Inc.
            16.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.1.2. Product Portfolio
            16.1.3. SWOT Analysis
            16.1.4. Financial Overview
            16.1.5. Strategic Overview
    16.2 Terumo BCT
            16.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.2.2. Product Portfolio
            16.2.3. SWOT Analysis
            16.2.4. Financial Overview
            16.2.5. Strategic Overview
    16.3 Merck KGaA
            16.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2. Product Portfolio
            16.3.3. SWOT Analysis
            16.3.4. Financial Overview
            16.3.5. Strategic Overview
    16.4 Beckman Coulter Inc.
            16.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.4.2. Product Portfolio
            16.4.3. SWOT Analysis
            16.4.4. Financial Overview
            16.4.5. Strategic Overview
    16.5  Miltenyi Biotec
            16.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.5.2. Product Portfolio
            16.5.3. SWOT Analysis
            16.5.4. Financial Overview
            16.5.5. Strategic Overview
    16.6 Lonza Group Ltd.
            16.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.6.2. Product Portfolio
            16.6.3. SWOT Analysis
            16.6.4. Financial Overview
            16.6.5. Strategic Overview
    16.7 Stemcell Technologies Inc.
            16.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.7.2. Product Portfolio
            16.7.3. SWOT Analysis
            16.7.4. Financial Overview
            16.7.5. Strategic Overview
    16.8  GE Healthcare
            16.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.8.2. Product Portfolio
            16.8.3. SWOT Analysis
            16.8.4. Financial Overview
            16.8.5. Strategic Overview
    16.9 Corning Inc.
            16.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.9.2. Product Portfolio
            16.9.3. SWOT Analysis
            16.9.4. Financial Overview
            16.9.5. Strategic Overview
    16.10 Sartorius Stedim Biotech
            16.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.10.2. Product Portfolio
            16.10.3. SWOT Analysis
            16.10.4. Financial Overview
            16.10.5. Strategic Overview
17. FutureWise SME Key Takeaway Points for Client

Tables

Figures